In the aftermath of the tragic death of 19 children through a poisonous cough syrup in Chhindwara, Madhya Pradesh, a drug inspection team intensive checks has started in medical stores in the Rajgarh district. As a precaution, the authorities in Rajgarh have all the cold and cough syrups tested, with samples being collected from several pharmacies.
All 19 deaths have been associated with Coldrif-Houst Syrup, which has been positively tested on Diethyleneglycol (DEG), an industrial toxic chemical that is known to cause kidney failure.
About 600 bottles of cough syrup have been found in Chhindwara, of which 443 have already been found.
In connection with this, too, the district administration of Indore has taken strict measures against the largest drug market in the state, with more than 50 samples from three pharmacies seized.
In the meantime, the authorities in Rajasthan, where drugs that have not passed the quality controls are still in circulation, now that all cough syrup samples are testing in government laboratories, which is checked for Deg- and Dextramethorfanhydrobid levels.
Samples will be collected from all 65 pharmaceutical companies in Rajasthan, while syrups from companies outside the state will be obtained from traders.
In addition to Madhya Pradesh, various other states, including Uttar Pradesh, Kerala, Tamil Nadu, Jharkhand, Maharashtra and Punjab, the Coldrif-Houst syrup have banned.
Here are the latest developments:
In Rajgarh in Madhya Pradesh his researchers started his action after they discovered that many medical stores were registered in the name of someone else, while untrained persons sold or prescribed recipes.
Research also revealed that cold syrups were still being sold that were not allowed to be given to children under the age of four. The drug inspector stated that a list of such syrups has been drawn up and that shop operators have been instructed to return it to the company.
In Indore, cough syrups were found in various pharmacies without bills and batch numbers. Civil servants have prepared to take samples of the suspected drugs and to send them for laboratory tests.
Chhattisgarh is also alert. Chhattisgarh head minister Vijay Sharma said that no cough syrup is given to children under the age of two.
Gujarat FDA has inspected two pharmaceutical companies and found two de-hoest syrups, Respifresh Tr & Relife. Retailers and distributors are instructed to immediately prohibit their sale.
Show-Cause Notification has been sent to Sresan Pharmaceuticals, based in Tamil Nadu, the manufacturer of Coldrif Syrup. India Today research exposes shocking errors and unsanitary conditions in the Kancheepuram factory.
The government of Kerala has forbidden distribution of medicines made by Sresan Pharmaceuticals. The decision follows the steps of the Tamil Nadu Drugs Controller to withdraw the license of the company.
The congress has demanded a judicial investigation into the case, strict measures against those responsible and compensation for the families of the victims.
The head of the Indian Medical Association, Dilip Bhanushal, defended Soni and blamed the pharmaceutical company and the government for systemic shortcomings in drug regulation.
– ends
Coordinate
#Deaths #cough #syrup #pharmacies #Madhya #Pradesh #radar #tests #Rajasthan